Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-61,829
Closed -$8.16M 36
2024
Q1
$8.16M Hold
61,829
0.43% 52
2023
Q4
$6.74M Sell
61,829
-13,599
-18% -$1.41M 0.4% 51
2023
Q3
$7.77M Sell
75,428
-253,951
-77% -$27.4M 0.26% 54
2023
Q2
$38M Hold
329,379
1.25% 31
2023
Q1
$35M Buy
329,379
+300,517
+1,041% +$32.4M 1.25% 32
2022
Q4
$3.2M Hold
28,862
0.12% 65
2022
Q3
$2.49M Buy
28,862
+1,889
+7% +$169K 0.1% 68
2022
Q2
$2.46M Buy
26,973
+2,561
+10% +$227K 0.09% 67
2022
Q1
$2M Buy
24,412
+1,375
+6% +$108K 0.07% 62
2021
Q4
$1.77M Buy
23,037
+962
+4% +$76.6K 0.06% 68
2021
Q3
$1.66M Sell
22,075
-11,189
-34% -$851K 0.06% 70
2021
Q2
$2.59M Buy
33,264
+2,084
+7% +$155K 0.1% 58
2021
Q1
$2.29M Sell
31,180
-406,409
-93% -$30M 0.1% 59
2020
Q4
$34.2M Hold
437,589
1.52% 28
2020
Q3
$34.6M Sell
437,589
-12,161
-3% -$953K 1.96% 15
2020
Q2
$33.2M Buy
449,750
+1,757
+0.4% +$132K 2.1% 11
2020
Q1
$32.9M Hold
447,993
2.52% 9
2019
Q4
$38.9M Buy
447,993
+47,059
+12% +$3.87M 2.39% 9
2019
Q3
$32.2M Hold
400,934
1.06% 8
2019
Q2
$32.1M Sell
400,934
-3,921
-1% -$300K 1.08% 9
2019
Q1
$32.1M Hold
404,855
1.12% 8
2018
Q4
$29.5M Hold
404,855
1.16% 8
2018
Q3
$27.4M Hold
404,855
0.93% 12
2018
Q2
$23.4M Sell
404,855
-115,306
-22% -$6.51M 0.88% 15
2018
Q1
$27M Hold
520,161
1.23% 11
2017
Q4
$27.9M Buy
520,161
+105,383
+25% +$5.84M 1.27% 10
2017
Q3
$25.3M Hold
414,778
1.23% 10
2017
Q2
$25.4M Buy
414,778
+29,408
+8% +$1.79M 1.28% 6
2017
Q1
$23.4M Hold
385,370
1.2% 7
2016
Q4
$21.6M Buy
385,370
+140,316
+57% +$8.21M 1.17% 10
2016
Q3
$14.6M Buy
+245,054
New +$14.3M 1.09% 28

Other funds holding MRK

Wafra Inc's MRK Position: Q2 2024 in Review

Wafra Inc sold out of Merck (MRK) in Q2 2024, closing a stake of 61,829 shares — an estimated $8.16M sold.

Wafra Inc first reported a position in MRK in Q3 2016 and held it in 31 quarters. The position peaked at $38.9M in Q4 2019. 3,545 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Wafra Inc reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • Wafra Inc sold 61,829 Merck shares in Q2 2024, an estimated $8.16M.
  • Wafra Inc first reported a position in Merck in Q3 2016 and held it in 31 quarters.
  • Wafra Inc's Merck position peaked at $38.9M in Q4 2019.
  • 3,545 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Wafra Inc's 13F filing for Q2 2024, filed 5 Aug 2024.